Anglais

Subject ID, age at diagnosis, ethnicity, gender, relapse and vital status, if patient receive a bone marrow transplant, primary treatment protocol, disease code, genetic lesions, characteristic of specimen including tumor purity, type of specimen, and tissue site where from the specimen was obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.

6 Formulaires  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, consent group, subject source, subject source ID, and affection status of participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    3. Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    4. Sample ID, body site where sample was collected, analyte type of samples, tumor status, histological type of samples, and primary tumor location obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    5. Subject ID, age at diagnosis, ethnicity, gender, relapse and vital status, if patient receive a bone marrow transplant, primary treatment protocol, disease code, genetic lesions, characteristic of specimen including tumor purity, type of specimen, and tissue site where from the specimen was obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    6. Sample ID and GEO accession ID of participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
pht003037
Description

pht003037

De-identified subject's ID
Description

SUBJID

Type de données

text

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C2348585
Age at Diagnosis (Years)
Description

ageAtDxYears

Type de données

integer

Unités de mesure
  • Years
Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0011900
Years
Additional Info (usually regarding Molecular Testing)
Description

additionalInfo

Type de données

string

Alias
UMLS CUI [1,1]
C1546922
Primary treatment protocol [AML97, AML02, AML91, AML86/AML87]
Description

primaryProtocol

Type de données

text

Alias
UMLS CUI [1,1]
C1708063
Did the patient relapse?
Description

relapse

Type de données

text

Alias
UMLS CUI [1,1]
C0699753
Did the patient receive a bone marrow transplant?
Description

bmt

Type de données

text

Alias
UMLS CUI [1,1]
C0005961
Genetic lesions
Description

geneticLesions

Type de données

string

Alias
UMLS CUI [1,1]
C0314603
UMLS CUI [1,2]
C0221198
Gender
Description

gender

Type de données

text

Alias
UMLS CUI [1,1]
C0079399
Ethnicity
Description

ethnicity

Type de données

text

Alias
UMLS CUI [1,1]
C0015031
Vital status
Description

vitalStatus

Type de données

text

Alias
UMLS CUI [1,1]
C3846084
Tumor purity
Description

tumorPurity

Type de données

string

Alias
UMLS CUI [1,1]
C4288090
Disease code AMLM7
Description

diseaseCode

Type de données

text

Alias
UMLS CUI [1,1]
C0279632
Type of specimen
Description

typeOfSpecimen

Type de données

text

Alias
UMLS CUI [1,1]
C0456204
Tissue site [Bone Marrow, Peripheral Blood]
Description

tissueSite

Type de données

text

Alias
UMLS CUI [1,1]
C0200345
UMLS CUI [1,2]
C1545955
Retour au début de la page

Similar models

Subject ID, age at diagnosis, ethnicity, gender, relapse and vital status, if patient receive a bone marrow transplant, primary treatment protocol, disease code, genetic lesions, characteristic of specimen including tumor purity, type of specimen, and tissue site where from the specimen was obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.

6 Formulaires
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, consent group, subject source, subject source ID, and affection status of participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    3. Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    4. Sample ID, body site where sample was collected, analyte type of samples, tumor status, histological type of samples, and primary tumor location obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    5. Subject ID, age at diagnosis, ethnicity, gender, relapse and vital status, if patient receive a bone marrow transplant, primary treatment protocol, disease code, genetic lesions, characteristic of specimen including tumor purity, type of specimen, and tissue site where from the specimen was obtained from participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
    6. Sample ID and GEO accession ID of participants with acute myeloblastic leukemia and involved in the "Analysis of Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing" project.
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht003037
SUBJID
Item
De-identified subject's ID
text
C4684638 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
ageAtDxYears
Item
Age at Diagnosis (Years)
integer
C0001779 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
additionalInfo
Item
Additional Info (usually regarding Molecular Testing)
string
C1546922 (UMLS CUI [1,1])
primaryProtocol
Item
Primary treatment protocol [AML97, AML02, AML91, AML86/AML87]
text
C1708063 (UMLS CUI [1,1])
Item
Did the patient relapse?
text
C0699753 (UMLS CUI [1,1])
relapse
Code List
Did the patient relapse?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Persistent disease (PD)
CL Item
Unknown (UN)
Item
Did the patient receive a bone marrow transplant?
text
C0005961 (UMLS CUI [1,1])
bmt
Code List
Did the patient receive a bone marrow transplant?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Unknown (UN)
geneticLesions
Item
Genetic lesions
string
C0314603 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
Item
Gender
text
C0079399 (UMLS CUI [1,1])
gender
Code List
Gender
CL Item
Male (M)
CL Item
Female (F)
Item
Ethnicity
text
C0015031 (UMLS CUI [1,1])
ethnicity
Code List
Ethnicity
CL Item
White (W)
CL Item
Black (B)
CL Item
No Data (ND)
Item
Vital status
text
C3846084 (UMLS CUI [1,1])
vitalStatus
Code List
Vital status
CL Item
Alive (A)
CL Item
Deceased (D)
CL Item
Unknown (UN)
tumorPurity
Item
Tumor purity
string
C4288090 (UMLS CUI [1,1])
diseaseCode
Item
Disease code AMLM7
text
C0279632 (UMLS CUI [1,1])
Item
Type of specimen
text
C0456204 (UMLS CUI [1,1])
typeOfSpecimen
Code List
Type of specimen
CL Item
DNA (DNA)
CL Item
DNA, RNA (DNA, RNA)
tissueSite
Item
Tissue site [Bone Marrow, Peripheral Blood]
text
C0200345 (UMLS CUI [1,1])
C1545955 (UMLS CUI [1,2])
Retour au début de la page